Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy

被引:0
作者
Marie T. Aouad
Waseem S. Alfahel
Roland N. Kaddoum
Sahar M. Siddik-Sayyid
机构
[1] American University of Beirut Medical Center,Department of Anaesthesiology
来源
BMC Anesthesiology | / 17卷
关键词
Neuromuscular blockade; Sugammadex; Rocuronium;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 106 条
[11]  
Marotta ML(1998)Interval estimation for the difference between independent proportions: comparison of eleven methods Stat Med 17 610-9
[12]  
Gourdin M(2010)Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose–response relationship Br J Anaesth 105 149-55
[13]  
Donnez O(1979)Pharmacokinetics and pharmacological effects of neostigmine in man Br J Clin Pharmacol 7 621-9
[14]  
Kopman AF(2007)Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function Anesthesiology 107 8-15
[15]  
Naguib M(2017)Diaphragmatic and intercostal electromyographic activity during neostigmine, sugammadex and neostigmine–sugammadex-enhanced recovery after neuromuscular blockade: A randomised controlled volunteer study Eur J Anaesthesiol 34 543-7
[16]  
Lindekaer AL(2012)Use of sugammadex after neostigmine incomplete reversal of rocuronium-induced neuromuscular blockade Rev Bras Anestesiol 62 547-55
[17]  
Halvor Springborg H(2015)The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade Korean J Anesthesiol 68 340-3
[18]  
Istre O(2012)Unrestricted access to sugammadex: impact on neuromuscular blocking agent choice, reversal practice and associated healthcare costs Anaesth Intensive Care 40 217-20
[19]  
Pongracz A(2012)Is sugammadex economically viable for routine use Curr Opin Anaesthesiol 25 1045-54
[20]  
Szatmari S(2015)Limiting the accessibility of cost-prohibitive drugs reduces overall anesthetic drug costs: a retrospective before and after analysis Can J Anaesth 62 333-9